ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Regenerative Medicine (ISSN: 1746-0751)

Publisher: Future Science Group

ISSN-L: 1746-0751

ISSN: 1746-0751

E-ISSN: 1746-076X

IF(Impact Factor) : 2017 Evaluation Pending

Website:

Description

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it's all about regeneration and not a specific platform technology. The journal's scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.
Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.
Regenerative Medicine exclusively supports all avenues that lead to the replacement or regeneration of human cells, tissue or organs, to restore or establish normal function. The sector is complex, rapidly evolving and multidisciplinary in nature, however, Regenerative Medicine is highly dynamic and has always embraced the progress made by the field and moved accordingly to support the critical issues including:
Bench-to-bedside translation
Tissue engineering and organ replacement
Regenerative pharmacology
Cell and gene therapy
Regenerative nanotechnology
Manufacturing and cost of goods
Regulatory and reimbursement
Ethical and legal perspectives
Business models and commercialization
Government policy
Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.
Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

Last modified: 2017-08-06 12:22:22

Volumes

  • No Archives